Chaperone Therapeutics
Raleigh
About Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding: the underlying causes of neurodegenerative and other rare diseases.Their therapeutic approaches elevate the natural protein folding and stress protection mechanisms to prevent protein misfolding and the ensuing cell dysfunction and death. Chaperone’s unique drug discovery platforms, broad knowledge in small molecule optimization and expertise in animal models of protein misfolding disease and clinical evaluation propel their therapeutic discovery programs forward.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $456.6K
- Funding stage: Seed
- Last round: Seed (Jan 2017)
- Website: chaperonetherapeutics.com
- Phone: 919-619-8296
Industries & Categories
Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/chaperone-therapeutics-79655 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.